These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
418 related items for PubMed ID: 30557983
1. Direct comparison of choline PET/CT and MRI in the diagnosis of lymph node metastases in patients with prostate cancer. Huang SM, Yin L, Yue JL, Li YF, Yang Y, Lin ZC. Medicine (Baltimore); 2018 Dec; 97(50):e13344. PubMed ID: 30557983 [Abstract] [Full Text] [Related]
2. Diagnostic Performance of Radiolabeled Prostate-Specific Membrane Antigen Positron Emission Tomography/Computed Tomography for Primary Lymph Node Staging in Newly Diagnosed Intermediate to High-Risk Prostate Cancer Patients: A Systematic Review and Meta-Analysis. Kim SJ, Lee SW, Ha HK. Urol Int; 2019 Dec; 102(1):27-36. PubMed ID: 30269140 [Abstract] [Full Text] [Related]
4. More advantages in detecting bone and soft tissue metastases from prostate cancer using 18F-PSMA PET/CT. Pianou NK, Stavrou PZ, Vlontzou E, Rondogianni P, Exarhos DN, Datseris IE. Hell J Nucl Med; 2019 Dec; 22(1):6-9. PubMed ID: 30843003 [Abstract] [Full Text] [Related]
5. Comparison of PSMA-PET/CT, choline-PET/CT, NaF-PET/CT, MRI, and bone scintigraphy in the diagnosis of bone metastases in patients with prostate cancer: a systematic review and meta-analysis. Zhou J, Gou Z, Wu R, Yuan Y, Yu G, Zhao Y. Skeletal Radiol; 2019 Dec; 48(12):1915-1924. PubMed ID: 31127357 [Abstract] [Full Text] [Related]
6. Diagnostic performance of choline PET/CT for the detection of bone metastasis in prostate cancer: A systematic review and meta-analysis. Guo Y, Wang L, Hu J, Feng D, Xu L. PLoS One; 2018 Dec; 13(9):e0203400. PubMed ID: 30192819 [Abstract] [Full Text] [Related]
7. Positron emission tomography (PET) and magnetic resonance imaging (MRI) for the assessment of axillary lymph node metastases in early breast cancer: systematic review and economic evaluation. Cooper KL, Meng Y, Harnan S, Ward SE, Fitzgerald P, Papaioannou D, Wyld L, Ingram C, Wilkinson ID, Lorenz E. Health Technol Assess; 2011 Jan; 15(4):iii-iv, 1-134. PubMed ID: 21276372 [Abstract] [Full Text] [Related]
8. 18 F-prostate specific membrane antigen positron emission tomography/computerized tomography for lymph node staging in medium/high risk prostate cancer: A systematic review and meta-analysis. Lv Z, Song L, Wang M, Hou H, Li H, Wang X, Wang J, Wang J, Liu M. Chin Med J (Engl); 2024 Apr 20; 137(8):949-958. PubMed ID: 37690993 [Abstract] [Full Text] [Related]
9. Diagnostic accuracy of F18 flucholine PET/CT for preoperative lymph node staging in newly diagnosed prostate cancer patients; a systematic review and meta-analysis. Kim SJ, Lee SW. Br J Radiol; 2019 Sep 20; 92(1101):20190193. PubMed ID: 31265330 [Abstract] [Full Text] [Related]
12. Diagnostic accuracy of C-11 choline and C-11 acetate for lymph node staging in patients with bladder cancer: a systematic review and meta-analysis. Kim SJ, Koo PJ, Pak K, Kim IJ, Kim K. World J Urol; 2018 Mar 20; 36(3):331-340. PubMed ID: 29294164 [Abstract] [Full Text] [Related]
13. A Comprehensive Comparison of CT, MRI, Positron Emission Tomography or Positron Emission Tomography/CT, and Diffusion Weighted Imaging-MRI for Detecting the Lymph Nodes Metastases in Patients with Cervical Cancer: A Meta-Analysis Based on 67 Studies. Liu B, Gao S, Li S. Gynecol Obstet Invest; 2017 Mar 20; 82(3):209-222. PubMed ID: 28183074 [Abstract] [Full Text] [Related]
14. MRI and FDG-PET/CT based assessment of axillary lymph node metastasis in early breast cancer: a meta-analysis. Liang X, Yu J, Wen B, Xie J, Cai Q, Yang Q. Clin Radiol; 2017 Apr 20; 72(4):295-301. PubMed ID: 28139203 [Abstract] [Full Text] [Related]
15. PET-CT versus MRI in the diagnosis of lymph node metastasis of cervical cancer: A meta-analysis. He T, Sun J, Wu J, Wang H, Liang C, Wang H, Li S, Su S. Microsc Res Tech; 2022 May 20; 85(5):1791-1798. PubMed ID: 34981608 [Abstract] [Full Text] [Related]
16. Diagnostic value of dual time-point 18 F-FDG PET/CT versus single time-point imaging for detection of mediastinal nodal metastasis in non-small cell lung cancer patients: a meta-analysis. Shen G, Hu S, Deng H, Jia Z. Acta Radiol; 2015 Jun 20; 56(6):681-7. PubMed ID: 24917609 [Abstract] [Full Text] [Related]
17. Diagnostic accuracy of F-18 FDG PET or PET/CT for detection of lymph node metastasis in clinically node negative head and neck cancer patients; A systematic review and meta-analysis. Kim SJ, Pak K, Kim K. Am J Otolaryngol; 2019 Jun 20; 40(2):297-305. PubMed ID: 30473166 [Abstract] [Full Text] [Related]
18. Final analysis of a prospective trial on functional imaging for nodal staging in patients with prostate cancer at high risk for lymph node involvement. Van den Bergh L, Lerut E, Haustermans K, Deroose CM, Oyen R, Isebaert S, Budiharto T, Ameye F, Mottaghy FM, Bogaerts K, Van Poppel H, Joniau S. Urol Oncol; 2015 Mar 20; 33(3):109.e23-31. PubMed ID: 25655681 [Abstract] [Full Text] [Related]
19. Detection of recurrent prostate cancer after radical prostatectomy: comparison of 11C-choline PET/CT with pelvic multiparametric MR imaging with endorectal coil. Kitajima K, Murphy RC, Nathan MA, Froemming AT, Hagen CE, Takahashi N, Kawashima A. J Nucl Med; 2014 Feb 20; 55(2):223-32. PubMed ID: 24434294 [Abstract] [Full Text] [Related]
20. Utility of choline positron emission tomography/computed tomography for lymph node involvement identification in intermediate- to high-risk prostate cancer: a systematic literature review and meta-analysis. Evangelista L, Guttilla A, Zattoni F, Muzzio PC, Zattoni F. Eur Urol; 2013 Jun 20; 63(6):1040-8. PubMed ID: 23036576 [Abstract] [Full Text] [Related] Page: [Next] [New Search]